DK1610817T3 - Infektiøs bronkitis virus med et ændret spike-gen - Google Patents

Infektiøs bronkitis virus med et ændret spike-gen

Info

Publication number
DK1610817T3
DK1610817T3 DK04716603T DK04716603T DK1610817T3 DK 1610817 T3 DK1610817 T3 DK 1610817T3 DK 04716603 T DK04716603 T DK 04716603T DK 04716603 T DK04716603 T DK 04716603T DK 1610817 T3 DK1610817 T3 DK 1610817T3
Authority
DK
Denmark
Prior art keywords
infectious bronchitis
ibv
altered
bronchitis virus
spike gene
Prior art date
Application number
DK04716603T
Other languages
English (en)
Inventor
David Cavanagh
Paul Britton
Ian Tarpey
Original Assignee
Intervet Int Bv
Animal Health Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Animal Health Inst filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK1610817T3 publication Critical patent/DK1610817T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK04716603T 2003-03-03 2004-03-03 Infektiøs bronkitis virus med et ændret spike-gen DK1610817T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075623 2003-03-03
PCT/EP2004/050247 WO2004078203A2 (en) 2003-03-03 2004-03-03 Infectious bronchitis virus with an altered spike gene

Publications (1)

Publication Number Publication Date
DK1610817T3 true DK1610817T3 (da) 2010-01-25

Family

ID=32946897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04716603T DK1610817T3 (da) 2003-03-03 2004-03-03 Infektiøs bronkitis virus med et ændret spike-gen

Country Status (11)

Country Link
US (1) US7445785B2 (da)
EP (1) EP1610817B1 (da)
AT (1) ATE445412T1 (da)
BR (1) BRPI0407948B1 (da)
DE (1) DE602004023594D1 (da)
DK (1) DK1610817T3 (da)
ES (1) ES2333223T3 (da)
PL (1) PL1610817T3 (da)
PT (1) PT1610817E (da)
SI (1) SI1610817T1 (da)
WO (1) WO2004078203A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072976A1 (es) 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
KR101092977B1 (ko) 2009-03-09 2011-12-26 대한민국 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신
GB0911794D0 (en) 2009-07-07 2009-08-19 Animal Health Inst Chimaeric protein
US20140141043A1 (en) * 2012-11-16 2014-05-22 Auburn University Compositions, vectors, kits, and methods for immunizing against avian infectious bronchitis virus
GB201308057D0 (en) 2013-05-03 2013-06-12 Pirbright Inst The Protein
GB201413020D0 (en) 2014-07-23 2014-09-03 Pribright The Inst Coronavirus
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus
BR112021008390A2 (pt) 2018-10-31 2021-09-28 Boehringer Ingelheim Vetmedica Gmbh Vacina de ibv h52 com proteína da espícula heteróloga
CN120290498A (zh) * 2018-10-31 2025-07-11 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN114174321B (zh) 2019-05-10 2025-04-25 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s2亚基
CN110819599B (zh) * 2019-11-22 2023-05-19 华南农业大学 一种预防台湾型传染性支气管炎的疫苗株
US20240000920A1 (en) 2020-11-12 2024-01-04 Intervet Inc. Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7350798A (en) * 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
PT1259257E (pt) 2000-02-29 2010-06-01 Wyeth Llc Protecção in ovo contra a bronquite infecciosa
EP1470218B1 (en) 2001-05-17 2010-07-07 Universiteit Utrecht Corona-virus-like particles comprising functionally deleted genomes

Also Published As

Publication number Publication date
WO2004078203A2 (en) 2004-09-16
SI1610817T1 (sl) 2010-01-29
WO2004078203A3 (en) 2004-11-25
EP1610817A2 (en) 2006-01-04
ES2333223T3 (es) 2010-02-18
PL1610817T3 (pl) 2010-05-31
US20070154489A1 (en) 2007-07-05
BRPI0407948A (pt) 2006-03-07
BRPI0407948B1 (pt) 2014-10-21
PT1610817E (pt) 2010-01-18
ATE445412T1 (de) 2009-10-15
DE602004023594D1 (de) 2009-11-26
WO2004078203A9 (en) 2005-08-25
US7445785B2 (en) 2008-11-04
EP1610817B1 (en) 2009-10-14

Similar Documents

Publication Publication Date Title
DK1610817T3 (da) Infektiøs bronkitis virus med et ændret spike-gen
NO20006328D0 (no) Attenuerte negative trådvirus med endret interferonantagonistaktivitet for anvendelse som vaksiner og medikamenter
MX342639B (es) Virus de la influenza recombinantes de alta titulacion para vacunas y terapia genica.
WO2018140766A3 (en) Porcine coronavirus vaccines
JP2004527264A5 (da)
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
NO20090177L (no) Vaksiner for malaria
PH12022550541A1 (en) Development of a novel live attenuated african swine fever vaccine based in the deletion of gene i177l
MY207126A (en) 4/91 ibv vaccine with heterologous spike protein
MX2023003784A (es) Peptido derivado de proteina de sars-cov-2 y vacuna que lo contiene.
PH12017500216A1 (en) Vaccine in serotype-9 fowl adenovirus recombinant vector
WO2009080715A3 (en) Vaccines for malaria
AU2003288510A1 (en) Immunizing fish against viral infection
EP1395283A4 (en) HETEROLOGICAL PROTECTION, INDUCED BY IMMUNIZATION WITH THE INVAPLEX VACCINE
CY1106175T1 (el) Αλληλουχιες νουκλεϊνικου οξεος και αμινοξεος μολυσματικου ιου αναιμιας σολομων και χρηση τους ως εμβολια
TN2014000393A1 (en) Modified marek's disease virus, and vaccines made therefrom
WO2022047176A3 (en) Single-chain coronavirus viral membrane protein complexes
Chary et al. Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus
Oreshkova et al. Preliminary evaluation of a Bunyavirus vector for cancer immunotherapy
Jamali et al. A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model
ATE330969T1 (de) Impfstoffe basierend auf mutanten des virus der infektiösen bursal-krankheit
MX2023003651A (es) Virus de la diarrea epidemica porcina atenuado.
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
HUP0302343A2 (hu) Eljárások és vakcinák in ovo védettség biztosítására pulykákban előforduló rhinotracheitisz ellen